Dapagliflozin, an SGLT2 inhibitor, for diabetes

被引:19
作者
Hanefeld, Markolf [1 ]
Forst, Thomas [2 ]
机构
[1] Tech Univ Dresden, Ctr Clin Studies, Gesell Wissens & Technol Transfer, D-01307 Dresden, Germany
[2] Mainz Inst Clin Res & Dev, Mainz, Germany
关键词
MELLITUS;
D O I
10.1016/S0140-6736(10)60749-0
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:2196 / 2198
页数:3
相关论文
共 11 条
[1]   Effect of dapagliflozin in patients with type 2 diabetes who have inadequate glycaemic control with metformin: a randomised, double-blind, placebo-controlled trial [J].
Bailey, Clifford J. ;
Gross, Jorge L. ;
Pieters, Anne ;
Bastien, Arnaud ;
List, James F. .
LANCET, 2010, 375 (9733) :2223-2233
[2]   Urologic complications of diabetes [J].
Brown, JS ;
Wessells, H ;
Chancellor, MB ;
Howards, SS ;
Stamm, WE ;
Stapleton, AE ;
Steers, WD ;
Van Den Eeden, SK ;
McVary, KT .
DIABETES CARE, 2005, 28 (01) :177-185
[3]   Role of glucotoxicity and lipotoxicity in the pathophysiology of Type 2 diabetes mellitus and emerging treatment strategies [J].
Del Prato, S. .
DIABETIC MEDICINE, 2009, 26 (12) :1185-1192
[4]   Phlorizin: a review [J].
Ehrenkranz, JRL ;
Lewis, NG ;
Kahn, CR ;
Roth, J .
DIABETES-METABOLISM RESEARCH AND REVIEWS, 2005, 21 (01) :31-38
[5]   Cytokine secretion is impaired in women with diabetes mellitus [J].
Geerlings, SE ;
Brouwer, EC ;
van Kessel, KCPM ;
Gaastra, W ;
Stolk, RP ;
Hoepelman, AIM .
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2000, 30 (11) :995-1001
[6]   Role of the kidney in normal glucose homeostasis and in the hyperglycaemia of diabetes mellitus: therapeutic implications [J].
Gerich, J. E. .
DIABETIC MEDICINE, 2010, 27 (02) :136-142
[7]  
Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743
[8]   Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial [J].
Home, Philip D. ;
Pocock, Stuart J. ;
Beck-Nielsen, Henning ;
Curtis, Paula S. ;
Gomis, Ramon ;
Hanefeld, Markolf ;
Jones, Nigel P. ;
Komajda, Michel ;
McMurray, John J. V. .
LANCET, 2009, 373 (9681) :2125-2135
[9]   Sodium-glucose co-transporter-2 inhibitors: an emerging new class of oral antidiabetic drug [J].
Idris, Iskandar ;
Donnelly, Richard .
DIABETES OBESITY & METABOLISM, 2009, 11 (02) :79-88
[10]   Sodium-Glucose Co-Transport Inhibitors Progress and Therapeutic Potential in Type 2 Diabetes Mellitus [J].
Neumiller, Joshua J. ;
White, John R., Jr. ;
Campbell, R. Keith .
DRUGS, 2010, 70 (04) :377-385